Status:
COMPLETED
Internet Monitoring vs Medication to Control Blood Sugar in Type 2 Diabetes
Lead Sponsor:
Endocrine Research Society
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Managing blood sugar levels is important for patients with type 2 diabetes (T2DM) to minimize health problems and complications. One way for patients to notify doctors and receive feedback about their...
Detailed Description
1. Purpose: To determine the effectiveness of an Internet-based glucose monitoring system (IBGMS) in the absence of medication changes. 2. Hypothesis: IBGMS without medication changes is compa...
Eligibility Criteria
Inclusion
- Type 2 diabetes patients being treated with oral hypoglycemic agents
- HbA1c \> 8%
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be trained on using the Internet-Based Glucose Monitoring System
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet access on a computer
- No prior use or training on IBGMS
Exclusion
- Patient with medical conditions that may affect their study participation or results will be excluded.
- Patients using medications known to influence control of diabetes (eg steroids systemic or inhaled)
- Liver disease (AST (aspartate aminotransferase) or ALT (alanine aminotransferase) levels \> 2.5 times the reference level)
- Renal insufficient with a serum creatinine level \> 200 μmol/L
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02185755
Start Date
August 1 2014
End Date
August 1 2016
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Hugh Tildesley Inc.
Vancouver, British Columbia, Canada, V6E1M7